alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

 

**Written Statement of the Chief Executive Officer and Chief Financial Officer**

**Pursuant to 18 U.S.C. §1350**

 

Solely for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Alliant Energy Corporation (the “Company”), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2006 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ William D. Harvey

William D. Harvey

Chairman, President and Chief Executive Officer

 

/s/ Eliot G. Protsch

Eliot G. Protsch

Senior Executive Vice President and Chief Financial Officer

 

May 5, 2006
Case 7:07-cr-00374-CLB Document 30 Filed 07/11/2007 Page 1 of 1
<PAGE>   1
THE LAMSON & SESSIONS CO. AND SUBSIDIARIES

EXHIBIT (11) - COMPUTATION OF EARNINGS PER COMMON SHARE

The following table sets forth the computation of basic and diluted earnings per
share:

(Dollars and shares in thousands)

<TABLE>
<CAPTION>
                                                                 THIRD QUARTER ENDED                NINE MONTHS ENDED
                                                            ------------------------------     ------------------------------
                                                                1998             1997              1998             1997
                                                            -------------    -------------     -------------    -------------
<S>                                                         <C>              <C>               <C>              <C>           
BASIC EARNINGS (LOSS)-PER-SHARE COMPUTATION
Net Income (Loss)                                           $       3,611    $      (5,647)    $       5,636    $      (1,515)
                                                            =============    =============     =============    =============

Average Common Shares Outstanding                                  13,445           13,378            13,429           13,331
                                                            =============    =============     =============    =============

Basic Earnings (Loss) Per Share                             $        0.27    $       (0.42)             0.42    $       (0.11)
                                                            =============    =============     =============    =============


DILUTED EARNINGS (LOSS)-PER-SHARE COMPUTATION
Net Income (Loss)                                           $       3,611    $      (5,647)    $       5,636    $      (1,515)
                                                            =============    =============     =============    =============

Basic Shares Outstanding                                           13,445           13,378            13,429           13,331

Stock Options calculated under the Treasury Stock Method               30                -                84                -
                                                            -------------    -------------     -------------    -------------

Total Shares                                                       13,475           13,378            13,513           13,331
                                                            =============    =============     =============    =============

Diluted Earnings (Loss) Per Share                           $        0.27    $       (0.42)    $        0.42    $       (0.11)
                                                            =============    =============     =============    =============
</TABLE>

                                      -11-
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# FOR FURTHER INFORMATION CONTACT:

                        NPPTL Event Management, 3604 Collins Ferry Road, Suite 100, Morgantown, West Virginia 26505-2353, Telephone 304-599-5941 x138, Fax 304-225-2003, E-mail                         *npptlevents@cdc.gov*.                    

                        The Director, Management Analysis and Services Office, has been delegated the authority to sign                         **Federal Register**                         Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                    

Dated: November 30, 2005.

Diane Allen,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

[FR Doc. 05-23653 Filed 12-1-05; 10:03 am]

BILLING CODE 4163-18-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which could constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Podiatry Summer Research Fellowships.                    

*Date:*                         December 13, 2005.                    

*Time:*                         2 p.m to 3 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).                    

*Contact Person:*                         Michele L. Barnard, PhD, Scientific Review Administrator, Review                               ( print page 71324)                            Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8898,                         *barnardm@extra.niddk.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: November 18, 2005.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 05-23345 Filed 11-25-05; 8:45 am]

BILLING CODE 4140-01-M
Case 1:07-cr-00372-LBS     Document 9      Filed 10/16/2007     Page 1 of 1
#### SHEPHERD v. OLIVER

No. 330P82.

Case below: 57 N.C. App. 188.

Petition by defendant for discretionary review under G.S. 7A-31 denied 13 July 1982.
#### DEVELOPMENT CO v. ARBITRATION ASSOC.

No. 59 PC

Case below: 48 NC App 548

Petition by intervenor Hopkins for discretionary review under G.S. 7A-31 denied 6 January 1981.
Schwartz Levitsky Feldman llp

CHARTERED ACCOUNTANTS

TORONTO, MONTREAL, OTTAWA











Schwartz Levitsky Feldman llp

CHARTERED ACCOUNTANTS

TORONTO, MONTREAL, OTTAWA





















AUDITORS REPORT





To the Shareholders of

Bontan Corporation Inc.



We have audited the consolidated balance sheet of Bontan Corporation Inc. as at March 31, 2006 and the related consolidated statements of operations, shareholders' equity and cash flows for the year then ended. These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. The consolidated financial statements of Bontan Corporation Inc. as of March 31, 2005 and for the years ended March 31, 2005 and 2004, were audited by other auditors whose report dated July 27, 2005, expressed an unqualified opinion on those statements.



We conducted our audit in accordance with Canadian generally accepted auditing standards and with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform an audit to obtain reasonable assurance whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.



In our opinion, these consolidated financial statements present fairly, in all material respects, the financial position of the Company as at March 31, 2006 and the results of its operations and its cash flows for the year then ended, in accordance with Canadian generally accepted accounting principles which differ in certain respects from generally accepted accounting principles in the United States (refer to note 16).



SCHWARTZ LEVITSKY FELDMAN LLP



Toronto, Ontario, Canada

July 12, 2006

Chartered Accountants



Schwartz Levitsky Feldman llp

CHARTERED ACCOUNTANTS

TORONTO, MONTREAL, OTTAWA
## COURT OF APPEALS SECO ND DISTRICT OF T EXAS FORT WORTH N O

. 2

- 1 0

- 0 7 9

- C V I N R E G A R Y G E O R G E S T I C K L E S R E L A T O R

- - - - - - - - - - - - O R I G I N A L P R O C E E D I N G

- - - - - - - - - - - - 

### M E M O R A N D U M O P I N I O N 1

- - - - - - - - - - - - T h e c o u r t h a s c o n s i d e r e d r e l a t o r ’ s p e t i t i o n f o r w r i t o f m a n d a m u s a n d i s

o f t h e o p i n i o n t h a t r e l i e f s h o u l d b e d e n i e d

. A c c o r d i n g l y , r e l a t o r ’ s p e t i t i o n f o r

w r i t o f m a n d a m u s i s d e n i e d

. R e l a t o r s h a l l p a y a l l c o s t s o f t h i s o r i g i n a l p r o c e e d i n g , f o r w h i c h l e t

e x e c u t i o n i s s u e
.

P E R C U R I A M

P A N E L : D A U P H I N O T , L I V I N G S T O N , a n d M C C O Y , J J

. D E L I V E R E D : M a r c h 2 9 , 2 0 1 0

1

 S e e T e x
. R

. A p p
. P

. 4 7

. 4

.
LANCE, INC. AND SUBSIDIARIES
 EXHIBIT 32
 
  (1)
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
   /s/ David V. Singer
    
    
    

/s/ Rick D. PuckettDavid V. Singer
President and Chief Executive Officer
October 31, 2008
    
    
    

Rick D. Puckett
Executive Vice President, Chief Financial Officer,
Treasurer and Secretary
October 31, 2008
#### STATE v. JARRELL

No. 32 PC.

Case below: 24 N.C. App. 610.

Petition for writ of certiorari to North Carolina Court of Appeals denied 2 April 1975. Motion of Attorney General to dismiss appeal for lack of substantial constitutional question allowed 2 April 1975.
**Exhibit 32.1**

 

**FORM 10-Q**

 

**Section 1350 Certifications**

 

**Quarter ended March 31, 2008**

 

I,Herbert Lindo, Chairman, President and Principal Financial Officer ofKenilworth Systems Corporation (the “Company”), certify, pursuant to Section 906of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to thebest of my knowledge:

 

(1)     theQuarterly Report on Form 10-Q of the Company for the first quarter ended March 31,2008 (the “Report”) fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));and

 

(2)     theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

Dated:  May 13, 2008

 

 
|   | /s/  Herbert Lindo                                               |
|--------|------------------------------------------------------------------|
|   | Herbert  Lindo                                                   |
|   | Chairman,  Chief Executive Officer and Chief   Financial Officer |

 

----
Order entered October 22 , 2013

In The 

## Court of Appeals **Fifth District of Texas at Dallas** No. 05 - 13 - 00696 - CV IN THE INTEREST OF I . L. S., A CHILD On Appeal from the 255th Judicial District Court Dallas County, Texas Trial Court Cause No. DF - 09 - 7655 

### O RDER We DENY appellant’s October 7, 2013 second motion for reconsideration of the dismissal order and the jurisdictional brief filed. This appeal is now proceeding under appellate cause number 05

- 13

- 00958

- CV.
/s/ DAVID L. BRIDGES JUSTICE
### IN THE TENTH COURT OF APPEALS

No. 10
- 10
- 00290
- CR
IN RE LUTHER GABRIEL
Original Proceeding

MEMORANDUM OPINION
Luther Gabriel seeks a writ of mandamus compelling Respondent, the Honorable Deborah Oakes Evans, Judge of the 87th District Court of Freestone County, to rule on his motion for post

- conviction DNA testing. The State has filed a response demonstrating that Respondent has ruled on Gabriel’s motion

. 1 Therefore, the petition
for writ of mandamus is d ismiss ed as moot. See In re Luna , 3 17 S.W.3d 484, 484 (Tex. App.

— Amarillo 20 10, orig. proceeding); In re Medrano , No. 13

- 10

- 00122

- CR, 2010 Tex. App. LEXIS 1988, at *1

- 2 (Tex. App.

— Corpus Christi Mar. 16, 20 10, orig. proceeding) (per curiam) (not designated for publication).

1 The State attached a certified copy of the docket sheet in the underlying cause to its respo nse which reflects that Respondent denied Gabriel’s motion for post

- conviction DNA testing on October 4, 2010 because “1) No evidence exists to be subjected to DNA [testing], and 2) There was never any biological evidence collected that still exists or eve r existed that could be tested for DNA.”In re Gabriel Page 2 FELIPE REYNA Ju stice Before Chief Justice Gray, Justice Reyna, and Justice Davis Petition dismissed as moot Opinion delivered and filed October 20, 2010 Do not publish [OT06 ]
Case 7:07-cv-03391-CLB-GAY Document 12 Filed 10/19/2007 Page 1 of 2
Case 7:07-cv-03391-CLB-GAY Document 12 Filed 10/19/2007 Page 2 of 2
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000059479
<NAME>                        LILLY INDUSTRIES, INC.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                             NOV-30-1997
<PERIOD-START>                                DEC-1-1997
<PERIOD-END>                                  FEB-28-1997
<EXCHANGE-RATE>                               1.000
<CASH>                                              4,372
<SECURITIES>                                            0
<RECEIVABLES>                                      89,595
<ALLOWANCES>                                       (2,844)
<INVENTORY>                                        48,382
<CURRENT-ASSETS>                                  151,325
<PP&E>                                            129,201
<DEPRECIATION>                                    (48,857)
<TOTAL-ASSETS>                                    513,725
<CURRENT-LIABILITIES>                             102,127
<BONDS>                                                 0
<COMMON>                                           91,650
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<OTHER-SE>                                         33,985
<TOTAL-LIABILITY-AND-EQUITY>                      513,725
<SALES>                                           142,160
<TOTAL-REVENUES>                                  142,160
<CGS>                                              90,112
<TOTAL-COSTS>                                     128,708
<OTHER-EXPENSES>                                     (150)
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                  5,040
<INCOME-PRETAX>                                     8,562
<INCOME-TAX>                                        3,852
<INCOME-CONTINUING>                                     0
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                        4,710
<EPS-PRIMARY>                                         .20
<EPS-DILUTED>                                         .20
        


</TABLE>
CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. SECTION 1350)

August 29, 2003


In connection with the Quarterly Report of CEC Industries, Corp., a Nevada
corporation (the "Company"), on Form 10-Q for the quarter ending June
30, 2003 as filed with the Securities and Exchange Commission (the Report"),
I, Brian Dvorak, Chairman of the Board, and President, of the Company,
certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18
U.S.C. Section 1350), that to my knowledge:

1.  The Report fully complies with the requirements of section 13(a) or
    15(d) of the Securities Exchange Act of 1934; and

2.  The information contained in the Report fairly presents, in all
    material respects, the financial condition and result of
    operations of the Company.



                                            /s/ Brian Dvorak
                             -------------------------------------------
                                             Brian Dvorak
                                          Chief Financial Officer
#### STATE v. McCALL and STATE v. SANDERS and STATE v. HILL

No. 22 PC.

Case below: 12 N.C. App. 85.

Petition for writ of *certiorari*to North Carolina Court of Appeals denied 5 October 1971.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Transportation

###### Federal Motor Carrier Safety Administration 

# FOR FURTHER INFORMATION CONTACT:

Mr. Avelino Gutierrez, Chair, Unified Carrier Registration Board of Directors at (505) 827-4565. 

Dated: September 21, 2007. 

William A. Quade, 

Associate Administrator, Enforcement and Program Delivery. 

[FR Doc. 07-4765 Filed 9-24-07; 2:00 pm] 

BILLING CODE 4910-EX-P
#### THOMPSON v. THOMPSON

No. 83 PC.

Case below: 21 N.C. App. 215.

Petition for writ of certiorari to North Carolina Court of Appeals denied 4 June 1974.
opgn-ex41_11.htm



Exhibit 4.1



Number op Shares Specimen OpGen, inc. incorporated under the laws of the state of deleware see reverse for certain definitions common stock cusip 68373l 20 8 This certifies that: specimen – not negotiable is the owner of fully paid and non-assessable shares of common stock of $.01 par value each of opgen, inc. transferable on the books of the corporation in person or by duly authorized attorney upon surrender of this certificate duly endorsed or assigned. This certificate and the shares represented hereby are subject to the laws of the state of Delaware, and to the Certificate Incorporation and Bylaws of the Corporation, as now or hereafter amended. This certificate is not valid until countersigned by the Transfer Agent. WITNESS the facsimile seal of the corporation and the facsimile signatures of its duly authorized officers. DATED: countersigned Philadelphia stock transfer. Inc 2320 haverford rd. suite 230. Ardmore, PA 19003 Transfer Agent authorized signature  corporate SEAL 2001 Delaware Specimen not negotiable Chief financial officer CEO/President